{"transactions":[{"id":825476,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55389,"kind":"person","name":"Daniel Mark James","position":1,"cik":"0002092593","reported_name":"Daniel Mark James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-30T19:22:50.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal annual installments on the first three anniversaries of March 26, 2026."}],"balance_after":63000,"source":{"system":"sec-edgar","filing":"0001193125-26-132644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092593/000119312526132644/ownership.xml","form_type":"4"}},{"id":1015388,"issuer":{"id":7556,"kind":"organization","name":"ATOSSA THERAPEUTICS, INC."},"owners":[{"id":55389,"kind":"person","name":"Daniel Mark James","position":1,"cik":"0002092593","reported_name":"Daniel Mark James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-21T16:10:03.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":578000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":578000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":578000},"source":{"system":"sec-edgar","filing":"0001193125-25-245114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2092593/000119312525245114/ownership.xml","form_type":"4"}}]}